Future perspectives of circulating tumor DNA in colorectal cancer by C Nadal, T Winder, A Gerger, David Tougeron

Get full text

COVID-19 lockdown-related treatment modifications did not impact the outcome of digestive cancers: the Clin-COVIDICA prospective study by Violaine Randrian, Amale Dhimene, Armelle Pillet, Camille Evrard, Rayan Elfadel, Claire Boyer, Astrid Guyot d’Asnières de Salins, Isabelle Ingrand, Aurélie Ferru, Laetitia Rouleau, David Tougeron

Get full text

Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis... by Christelle de La Fouchardière, Jaafar Bennouna, David Tougeron, Thierry André, Christophe Tournigand, Christophe Borg, Romain Cohen, Thibault Mazard, Dewi Vernerey, Frédéric Pigneur, Julie Henriques, Aurélia Meurisse, Benoist Chibaudel, Leonard Depotte, Paula Nay

Get full text

RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer:... by Christelle de La Fouchardière, Jaafar Bennouna, David Tougeron, Magali Svrcek, Thierry André, Christophe Tournigand, Christophe Borg, Romain Cohen, Marie-Line Garcia-Larnicol, Thibault Mazard, Yves Menu, Dewi Vernerey, Aurélia Meurisse, Benoist Chibaudel

Get full text

Second malignancies in patients with deficient mismatch repair system/microsatellite instability-high colorectal cancer by Paul Franques, Pierre Moreau, Camille Evrard, Arnaud Chong-Si-Tsaon, Éric Frouin, Marie-Luce Auriault, Valérie Moulin, Audelaure Junca, Julie Godet, Lucie Lebeau, Roxane Aguillon, Gaëlle Tachon, Lucie Karayan-Tapon, David Tougeron

Get full text

First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: The French ACABi GERCOR PRONOBIL cohort by Nicolas Adamus, Julien Edeline, Julie Henriques, Nadim Fares, Thierry Lecomte, Anthony Turpin, Dewi Vernerey, Mathilde Vincens, Brice Chanez, David Tougeron, Christophe Tournigand, Eric Assenat, Matthieu Delaye, Sylvain Manfredi, Olivier Bouché, Nicolas Williet, Angelique Vienot, Lorraine Blaise, Léo Mas, Cindy Neuzillet, Alice Boilève, Gaël S. Roth

Get full text

Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma by David Tougeron, Christophe Louvet, Jérôme Desramé, Ludovic Evesque, Antoine Angelergues, Aurélien Carnot, Gilles Breysacher, Aziz Zaanan, Nicolas Etchepare, May Mabro, Laure Kaluzinski, Caroline Petorin, Benoist Chibaudel, Thomas Aparicio, Anaïs Bodere, Yves Rinaldi, Karine Le Malicot, Jean-François Emile, Côme Lepage, Aurélia Baures, Hanane Djamai, Valérie Taly, Pierre Laurent-Puig

Get full text

Sex and outcomes of patients with microsatellite instability-high and BRAF V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitors by Michael Hoffmeister, Hermann Brenner, Chiara Cremolini, Sara Lonardi, Filippo Pietrantonio, Julien Taieb, David Tougeron, Robyn L Ward, Marco Vitellaro, Thierry André, Pierre Laurent-Puig, Jitendra Jonnagaddala, Francesca Bergamo, Raghav Sundar, Claire Gallois, Michael J Overman, Jakob Nikolas Kather, Lisa Salvatore, Romain Cohen, Rossana Intini, Priya Jayachandran, Miriam Koopman, Javier Ros, Marwan Fakih, Vincenzo Nasca, Giacomo Mazzoli, Jeanine M L Roodhart, Filippo Ghelardi, Elena Elez, Durgesh Wankhede, Marta Ligero, Joseph Zhao, Koen Zwart, Jeroen Derksen, Nicholas Hawkins, Javier Carmona

Get full text